Effectiveness aNd Use of fosleVOdopa-foscarbidopa in Advanced Parkinson Disease in Real Life Setting
Latest Information Update: 29 Mar 2025
At a glance
- Drugs Foscarbidopa/Foslevodopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms ENVOL
- Sponsors AbbVie
Most Recent Events
- 27 Dec 2024 Planned End Date changed from 31 Mar 2027 to 1 Mar 2027.
- 27 Dec 2024 Planned primary completion date changed from 31 Mar 2027 to 1 Mar 2027.
- 18 Nov 2024 Status changed from not yet recruiting to recruiting.